IC
CORT icon

IEQ Capital’s Corcept Therapeutics CORT Stock Holding History

IEQ Capital’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.03M Buy
+92,394
New +$5.58M 0.04% 383
2026
Q1 		– Sell
-26,124
Closed -$909K – 1928
2025
Q4 		$909K Sell
26,124
-18,807
-42% -$1.48M ﹤0.01% 1081
2025
Q3 		$3.73M Buy
44,931
+20,599
+85% +$1.49M 0.01% 567
2025
Q2 		$1.79M Buy
24,332
+6,441
+36% +$467K 0.01% 678
2025
Q1 		$2.04M Buy
17,891
+7,844
+78% +$477K 0.02% 583
2024
Q4 		$506K Buy
+10,047
New +$526K ﹤0.01% 842

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IEQ Capital's CORT Position: Q2 2026 in Review

IEQ Capital opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 92,394 shares worth $8.03M. The stake represents 0.04% of the portfolio and ranks #383 among its holdings. This is a return to the name: IEQ Capital previously reported a position in CORT as recently as Q4 2025.

IEQ Capital first reported a position in CORT in Q4 2024 and has held it in 6 quarters since. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • IEQ Capital held 92,394 shares of Corcept Therapeutics worth $8.03M as of Q2 2026.
  • Corcept Therapeutics was a new IEQ Capital position in Q2 2026.
  • Corcept Therapeutics made up 0.04% of IEQ Capital's portfolio in Q2 2026, its #383 holding.
  • IEQ Capital first reported a position in Corcept Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.